Pharmaids Pharmaceuticals Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Recent quarter shows a slight revenue recovery to ₹5.24 Crore, indicating potential growth.
Reduction in material costs to 27.01% suggests improved cost efficiency.
Other income turned positive at ₹0.01 Crore, reflecting better financial management.

NEGATIVES

Consistent net losses, with the latest quarter reporting -₹2.56 Crore, raising concerns about profitability.
Operating profit margins remain negative, impacting overall financial health.
Declining revenues from prior quarters suggest ongoing challenges in generating sales.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Jun 25
Revenue	0	0	0.02	5.81	4.67	5.24	4.71	6.66
Expenses	1.62	1.03	1.33	12.78	8.91	8.75	8.72	13.88
Operating Profit	-1.62	-1.03	-1.31	-6.98	-4.23	-3.51	-4.01	-7.21
Other Income	0.37	-0.26	-0.90	0.12	0.01	0.01	0.01	0.04
Interest	0	0	0	0.77	0.26	0.34	0.48	1.20
Depreciation	0.01	0.01	0.01	0.63	0.57	0.61	0.64	0.61
Profit Before Tax	-1.21	-1.29	-2.21	-6.86	-4.30	-3.56	-4.01	-7.17
Tax	0.09	-0.78	-0.58	-0.53	-1.18	-1	-1	-1.86
Net Profit	-1.30	-0.50	-1.63	-6.33	-3.12	-2.56	-3.01	-5.31
Eps in Rs	-0.61	-0.24	-0.76	-2.82	-0.76	-0.73	-0.55	-1.41